Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo. 1991

M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892.

The respiratory epithelium is a potential site for somatic gene therapy for the common hereditary disorders alpha 1-antitrypsin (alpha 1AT) deficiency and cystic fibrosis. A replication-deficient adenoviral vector (Ad-alpha 1AT) containing an adenovirus major late promoter and a recombinant human alpha 1AT gene was used to infect epithelial cells of the cotton rat respiratory tract in vitro and in vivo. Freshly isolated tracheobronchial epithelial cells infected with Ad-alpha 1AT contained human alpha 1AT messenger RNA transcripts and synthesized and secreted human alpha 1AT. After in vivo intratracheal administration of Ad-alpha 1AT to these rats, human alpha 1AT messenger RNA was observed in the respiratory epithelium, human alpha 1AT was synthesized and secreted by lung tissue, and human alpha 1AT was detected in the epithelial lining fluid for at least 1 week.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D004646 Emphysema A pathological accumulation of air in tissues or organs.
D004848 Epithelium The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body. Mesothelium,Epithelial Tissue,Mesothelial Tissue,Epithelial Tissues,Mesothelial Tissues,Tissue, Epithelial,Tissue, Mesothelial,Tissues, Epithelial,Tissues, Mesothelial
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000256 Adenoviridae A family of non-enveloped viruses infecting mammals (MASTADENOVIRUS) and birds (AVIADENOVIRUS) or both (ATADENOVIRUS). Infections may be asymptomatic or result in a variety of diseases. Adenoviruses,Ichtadenovirus,Adenovirus,Ichtadenoviruses

Related Publications

M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
June 1995, Cancer gene therapy,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
July 1992, Proceedings of the National Academy of Sciences of the United States of America,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
January 1994, Human gene therapy,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
March 1996, Human gene therapy,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
March 2001, Human gene therapy,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
May 1995, The American journal of physiology,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
November 1998, Experimental eye research,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
June 2000, Gene therapy,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
May 1998, Australian and New Zealand journal of ophthalmology,
M A Rosenfeld, and W Siegfried, and K Yoshimura, and K Yoneyama, and M Fukayama, and L E Stier, and P K Pääkkö, and P Gilardi, and L D Stratford-Perricaudet, and M Perricaudet
May 1994, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!